Earlier quoted context omitted.
There are plenty of Biotech VCs in the bay area. The one I know best is Third Rock Ventures, but there are others. The timelines for success are extraordinarily long so it's not quite as splashy a space. It's almost impossible to "fail fast" with a "MVP" in the biotech space, so you have to put in tons of capital for a long time. That said personalized medicine should end up being interesting, but I think it's really…
Bull Shit. Biotech companies produce more MVP's then any other sector. Just because we don't need to test if the business will work (as much as say a facebook) we do need to test the science. My startup is working on infection resistant materials for around hospitals. Infections are a problem, if we solve it we will have customers, how many and at what cost is the question. But because science is the question, and it…
I think I see the experiments you're doing more as internal development. I.e. I run bits of my code dozens of times a day to make sure it's working (or not), which I see as analogous to running bench experiments.
Also, I'm thinking more about traditional pharma biotech where you can run tons of experiments but the drug has to be put into people at some point and there's actually a lot that can go wrong there that can't be easily forecast. The only time you get hints at whether your drug is "viable" is when you're in clinical trials and even then until succeeding in Phase III there's a ton of potentially catastrophic risk.
For the record I was a bench biochemist for the better part of a decade, so under no circumstances do I mean to denigrate bench science.